AI-generated summary
The authors compared a 595 nm pulsed dye laser alone with sequential 595 nm pulsed dye laser and 1,064 nm Nd:YAG laser treatment in a split-face randomized study of erythematotelangiectatic rosacea. They report that both approaches significantly reduced the erythema index with no difference between them, while the combined treatment caused less pain and fewer side effects and was preferred by patients.
- Participants
- 27
- Who or what was studied
- Adults with erythematotelangiectatic rosacea, with both cheeks treated in a split-face design
- Wavelengths
- 595 nm
- Limits stated in the abstract
- The study enrolled only 27 patients who completed it, and preference and satisfaction outcomes were self-reported.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 595 nm, 064 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.